Chemomab Therapeutics Analyst Ratings

BenzingaFeb 20 13:26 ET

Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsFeb 20 11:31 ET

Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $7

Moomoo NewsFeb 20 08:31 ET

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Blueprint Medicines (BPMC)

TipRanksFeb 20 08:16 ET

Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $11

Moomoo NewsFeb 19 08:31 ET

Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsNov 15, 2024 15:31 ET

Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Cuts Target Price to $11

Moomoo NewsNov 15, 2024 14:31 ET

Chemomab Therapeutics Analyst Ratings

BenzingaNov 15, 2024 10:55 ET

Roth MKM Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 15, 2024 09:33 ET

Roth MKM Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 18, 2024 09:34 ET

Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsAug 22, 2024 13:32 ET

Chemomab Therapeutics (CMMB) Gets a Buy From Oppenheimer

TipRanksAug 22, 2024 07:23 ET

Maxim Group Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsJul 27, 2024 08:32 ET

Roth MKM Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsJul 26, 2024 08:31 ET

Oppenheimer Maintains Chemomab Therapeutics(CMMB.US) With Buy Rating, Raises Target Price to $13

Moomoo NewsJul 25, 2024 15:32 ET

Chemomab Therapeutics Analyst Ratings

BenzingaMay 13, 2024 12:34 ET

Analysts Offer Insights on Healthcare Companies: Chemomab Therapeutics (CMMB), Fate Therapeutics (FATE) and Disc Medicine (IRON)

TipRanksMay 10, 2024 08:35 ET

Analysts Offer Insights on Healthcare Companies: Andlauer Healthcare Group (OtherANDHF), ACADIA Pharmaceuticals (ACAD) and Chemomab Therapeutics (CMMB)

TipRanksMay 6, 2024 07:55 ET

Chemomab Therapeutics Analyst Ratings

BenzingaMay 6, 2024 07:52 ET

Chemomab Therapeutics Analyst Ratings

BenzingaMar 8, 2024 08:47 ET